Labcorp Holdings Inc. (LH) reported $14.59B of revenue for the twelve months ended Sep 30, 2026. That is up 6.0% from the year before. Revenue for fiscal 2025 was $13.95B.

Yes. Labcorp Holdings Inc. earned $1.00B in net income for the twelve months ended Sep 30, 2026, a net margin of 6.9%.

How much cash and debt does LH have?

Labcorp Holdings Inc. reported $261.80M in cash and cash equivalents and $5.85B of debt on its most recent balance sheet in SEC filings.

How fast is LH revenue growing?

Labcorp Holdings Inc.'s revenue changed +7.2% in fiscal 2025, to $13.95B. Its compound annual growth rate was -0.0% over 5 years and +4.9% over 10 years.

What is LH gross margin?

Labcorp Holdings Inc.'s gross profit was $4.23B on $14.59B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 29.0%.

What is LH free cash flow?

Labcorp Holdings Inc. generated $1.29B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.81B less capital expenditures.

What is LH earnings per share?

Diluted earnings per share were $12.19 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did LH last report financial results?

The latest statements here come from Labcorp Holdings Inc.'s 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.

Where does this LH financial data come from?

Quantisnow builds these statements from the structured XBRL data Labcorp Holdings Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · LH

Labcorp Holdings Inc. (LH) financials

For the twelve months ended Sep 30, 2026, Labcorp Holdings Inc. reported $14.59B of revenue and $1.00B of net income.

Revenue, TTM: $14.59B
Revenue growth, YoY: +6.0%
Net income, TTM: $1.00B
Net income growth, YoY: +17.4%
Net margin: 6.9%
Free cash flow, TTM: $1.29B
EPS, diluted, TTM: $12.19
EPS growth, YoY: +19.5%
Cash: $261.80M
Total debt: $5.85B
P/E: 29.38
P/S: 2.02
Market cap: $29.50B

Annual revenue$13.95B

FY2016FY2025

Annual net income$876.50M

FY2016FY2025

Annual free cash flow$1.21B

FY2016FY2025

LH revenue and earnings growth

LH revenueQ3 2026$3.81B

Quarter YoY: +6.9%
QoQ: +2.1%
FY YoY: +7.2%
5Y CAGR: -0.0%
10Y CAGR: +4.9%

LH revenue was $3.81B in fiscal Q3 2026 (ended Sep 30, 2026), up 6.9% from a year earlier and up 2.1% from the prior quarter. For the full fiscal 2025 it was $13.95B, up 7.2% from fiscal 2024. Compound annual growth was -0.0% over 5 years and +4.9% over 10 years. It rose in 8 of the last 10 fiscal years.

LH net incomeQ3 2026$262.80M

Quarter YoY: +0.7%
QoQ: -12.0%
FY YoY: +17.5%
5Y CAGR: -10.8%
10Y CAGR: +7.2%

LH net income was $262.80M in fiscal Q3 2026 (ended Sep 30, 2026), up 0.7% from a year earlier and down 12.0% from the prior quarter. For the full fiscal 2025 it was $876.50M, up 17.5% from fiscal 2024. Compound annual growth was -10.8% over 5 years and +7.2% over 10 years. It rose in 6 of the last 10 fiscal years.

LH EPSQ3 2026$3.22

Quarter YoY: +3.2%
QoQ: -11.5%
FY YoY: +18.3%
5Y CAGR: -8.0%
10Y CAGR: +9.2%

LH diluted EPS was $3.22 in fiscal Q3 2026 (ended Sep 30, 2026), up 3.2% from a year earlier and down 11.5% from the prior quarter. For the full fiscal 2025 it was $10.46, up 18.3% from fiscal 2024. Compound annual growth was -8.0% over 5 years and +9.2% over 10 years.

LH free cash flowQ3 2026$412.20M

Quarter YoY: +47.0%
QoQ: +31.3%
FY YoY: +10.0%
5Y CAGR: -7.2%
10Y CAGR: +5.2%

LH free cash flow was $412.20M in fiscal Q3 2026 (ended Sep 30, 2026), up 47.0% from a year earlier and up 31.3% from the prior quarter. For the full fiscal 2025 it was $1.21B, up 10.0% from fiscal 2024. Compound annual growth was -7.2% over 5 years and +5.2% over 10 years. It rose in 7 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$13.95B	$13.01B	$12.16B	$11.86B	$13.14B	$13.98B	$11.55B	$11.33B	$10.31B	$9.55B
Cost of revenue	$9.94B	$9.38B	$8.80B	$8.15B	$8.14B	$9.03B	$8.30B	$8.16B	$7.22B	$6.70B
Gross profit	$4.01B	$3.62B	$3.36B	$3.71B	$4.99B	$4.95B	$3.25B	$3.18B	$3.09B	$2.85B
Selling, general and admin	$2.22B	$2.23B	$2.02B	$1.76B	$1.69B	$1.73B	$1.62B	$1.57B	$1.50B	$1.35B
Operating income	$1.38B	$1.09B	$725.60M	$1.44B	$3.05B	$2.45B	$1.33B	$1.33B	$1.31B	$1.27B
Interest expense	$224.10M	$208.30M	$199.60M	$179.80M	$211.80M	$207.40M	$240.70M	$244.20M	$235.10M	$219.10M
Income tax	$229.80M	$212.40M	$188.50M	$233.90M	$690.00M	$662.10M	$280.00M	$384.40M	-$155.40M	$360.70M
Net income	$876.50M	$746.00M	$418.00M	$1.28B	$2.38B	$1.56B	$823.80M	$883.70M	$1.23B	$711.80M
EPS, basic	$10.54	$8.89	$4.80	$14.05	$24.60	$15.99	$8.42	$8.71	$11.99	$6.94
EPS, diluted	$10.46	$8.84	$4.77	$13.97	$24.39	$15.88	$8.35	$8.61	$11.81	$6.82
Diluted shares	83.8M	84.4M	87.6M	91.6M	97.5M	98.0M	98.6M	102.6M	103.9M	104.3M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$532.30M	$1.52B	$536.80M	$320.60M	$1.38B	$1.32B	$337.50M	$426.80M	$316.60M	$433.60M
Receivables	$2.10B	$1.94B	$1.91B	$1.79B	$2.26B	$2.48B	$1.54B	$1.47B	$1.53B	$1.33B
Inventory	$534.70M	$493.20M	$474.60M	$470.60M	$401.40M	$423.20M	$244.70M	$237.30M	$227.20M	$205.20M
Current assets	$4.02B	$4.81B	$3.77B	$4.63B	$5.33B	$5.13B	$2.98B	$2.84B	$2.73B	$2.48B
Goodwill	$6.79B	$6.37B	$6.14B	$6.12B	$5.89B	$7.75B	$7.87B	$7.36B	$7.40B	$6.42B
Total assets	$18.39B	$18.38B	$16.73B	$20.16B	$20.39B	$20.07B	$18.05B	$16.19B	$16.67B	$14.25B
Current liabilities	$2.82B	$3.33B	$3.23B	$3.08B	$2.78B	$3.08B	$2.66B	$1.88B	$2.19B	$1.83B
Short-term debt	$500.10M	$1.00B	$999.80M	$301.30M	$1.50M	$376.70M	$415.20M	$10.00M	$417.50M	$549.50M
Long-term debt	$5.08B	$5.33B	$4.05B	$5.04B	$5.42B	$5.42B	$5.79B	$5.99B	$6.34B	$5.30B
Total debt	$5.58B	$6.33B	$5.05B	$5.34B	$5.42B	$5.80B	$6.21B	$6.00B	$6.76B	$5.85B
Total liabilities	$9.76B	$10.31B	$8.83B	$10.04B	$10.09B	$10.61B	$10.46B	$9.19B	$9.85B	$8.73B
Shareholders' equity	$8.62B	$8.05B	$7.88B	$10.10B	$10.27B	$9.44B	$7.64B	$7.05B	$6.80B	$5.52B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$1.64B	$1.59B	$1.33B	$1.96B	$3.11B	$2.14B	$1.44B	$1.31B	$1.50B	$1.20B
Capital expenditures	$434.50M	$489.90M	$453.60M	$429.30M	$421.50M	$381.70M	$400.20M	$379.80M	$312.90M	$278.90M
Free cash flow	$1.21B	$1.10B	$874.10M	$1.53B	$2.69B	$1.75B	$1.04B	$925.60M	$1.19B	$918.20M
Investing cash flow	-$1.19B	-$1.37B	-$1.17B	-$1.65B	-$884.60M	-$643.20M	-$1.28B	$206.70M	-$2.23B	-$795.70M
Financing cash flow	-$1.46B	$779.90M	-$59.30M	-$1.32B	-$2.07B	-$517.40M	-$252.70M	-$1.39B	$593.20M	-$671.00M
Dividends paid	$240.70M	$243.10M	$254.00M	$195.20M	-	-	-	-	-	-
Share repurchases	$450.00M	$250.10M	$1.00B	$1.10B	$1.67B	$100.00M	$450.00M	$700.00M	$338.10M	$43.90M
Stock-based compensation	$125.80M	$116.70M	$128.70M	$116.80M	$132.90M	$111.70M	$107.00M	$91.60M	$109.70M	$109.60M
Depreciation and amortization	$681.10M	$643.50M	$577.30M	$537.20M	$577.00M	$624.70M	$577.20M	$552.10M	$533.20M	$499.20M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	7.2%	7.0%	2.5%	-9.7%	-6.0%	21.0%	2.0%	9.9%	7.9%	10.1%
Net income growth, YoY	17.5%	78.5%	-67.3%	-46.2%	52.8%	88.9%	-6.8%	-28.0%	72.4%	62.7%
EPS growth, YoY	18.3%	85.3%	-65.9%	-42.7%	53.6%	90.2%	-3.0%	-27.1%	73.2%	56.8%
Gross margin	28.8%	27.9%	27.7%	31.3%	38.0%	35.4%	28.1%	28.0%	30.0%	29.9%
Operating margin	9.9%	8.4%	6.0%	12.1%	23.2%	17.5%	11.5%	11.7%	12.7%	13.3%
Net margin	6.3%	5.7%	3.4%	10.8%	18.1%	11.1%	7.1%	7.8%	11.9%	7.5%
Free cash flow margin	8.6%	8.4%	7.2%	12.9%	20.5%	12.5%	9.0%	8.2%	11.5%	9.6%
Return on equity	10.2%	9.3%	5.3%	12.7%	23.1%	16.5%	10.8%	12.5%	18.0%	12.9%
Return on assets	4.8%	4.1%	2.5%	6.3%	11.7%	7.8%	4.6%	5.5%	7.4%	5.0%
Current ratio	1.42	1.44	1.17	1.50	1.92	1.66	1.12	1.51	1.25	1.36
Debt to equity	0.65	0.79	0.64	0.53	0.53	0.61	0.81	0.85	0.99	1.06

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$3.81B	$3.73B	$3.54B	$3.52B	$3.56B	$3.53B	$3.35B	$3.33B	$3.28B	$3.22B	$3.18B	$3.03B
Cost of revenue	$2.70B	$2.62B	$2.52B	$2.52B	$2.54B	$2.48B	$2.40B	$2.43B	$2.38B	$2.29B	$2.28B	$2.21B
Gross profit	$1.11B	$1.11B	$1.01B	$993.20M	$1.03B	$1.05B	$948.00M	$896.30M	$904.40M	$926.40M	$897.30M	$821.40M
Selling, general and admin	$611.40M	$577.20M	$551.00M	$537.90M	$553.10M	$579.30M	$546.00M	$595.20M	$568.60M	$557.80M	$508.40M	$532.90M
Operating income	$402.10M	$451.60M	$380.80M	$267.60M	$396.60M	$394.50M	$326.00M	$216.50M	$254.10M	$294.80M	$321.30M	-$122.80M
Interest expense	$59.10M	$61.10M	$55.10M	$55.00M	$56.00M	$57.10M	$56.00M	$63.40M	$50.40M	$47.60M	$46.90M	$48.80M
Income tax	$64.90M	$87.30M	$41.70M	$25.70M	$75.50M	$66.40M	$62.20M	$40.20M	$41.00M	$62.10M	$69.10M	$19.70M
Net income	$262.80M	$298.70M	$277.80M	$164.70M	$261.10M	$237.90M	$212.80M	$143.40M	$169.30M	$205.30M	$228.00M	-$167.10M
EPS, basic	$3.24	$3.66	$3.37	$2.01	$3.14	$2.85	$2.54	$1.72	$2.02	$2.44	$2.71	-$1.86
EPS, diluted	$3.22	$3.64	$3.35	$1.98	$3.12	$2.84	$2.52	$1.72	$2.00	$2.43	$2.69	-$1.85
Diluted shares	81.6M	82.0M	82.9M	-	83.7M	83.9M	84.3M	-	84.4M	84.3M	84.7M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$261.80M	$141.80M	$981.10M	$532.30M	$598.10M	$647.30M	$369.40M	$1.52B	$1.52B	$265.10M	$99.30M	$536.80M
Receivables	$2.41B	$2.34B	$2.29B	$2.10B	$2.11B	$2.12B	$2.12B	$1.94B	$2.06B	$2.09B	$2.08B	$1.91B
Inventory	$538.40M	$562.20M	$497.70M	$534.70M	$521.50M	$508.10M	$488.30M	$493.20M	$483.10M	$441.80M	$475.00M	$474.60M
Current assets	$3.97B	$3.81B	$4.56B	$4.02B	$4.08B	$4.09B	$3.79B	$4.81B	$4.91B	$3.57B	$3.46B	$3.77B
Goodwill	$7.18B	$7.03B	$6.96B	$6.79B	$6.68B	$6.55B	$6.42B	$6.37B	$6.48B	$6.22B	$6.22B	$6.14B
Total assets	$18.92B	$18.53B	$19.09B	$18.39B	$18.26B	$18.06B	$17.60B	$18.38B	$18.61B	$16.71B	$16.53B	$16.73B
Current liabilities	$2.82B	$2.12B	$2.64B	$2.82B	$2.63B	$2.72B	$2.06B	$3.33B	$3.41B	$4.06B	$3.94B	$3.23B
Short-term debt	$601.20M	$900.0K	$500.40M	$500.10M	-	-	-	$1.00B	-	-	-	$999.80M
Long-term debt	$5.25B	$5.86B	$5.83B	$5.08B	$5.08B	$5.08B	$5.57B	$5.33B	$5.35B	$3.05B	$3.05B	$4.05B
Total debt	$5.85B	$5.86B	$6.33B	$5.58B	$5.08B	$5.08B	$5.57B	$6.33B	$5.35B	$3.05B	$3.05B	$5.05B
Total liabilities	$10.06B	$9.91B	$10.34B	$9.76B	$9.55B	$9.57B	$9.28B	$10.31B	$10.43B	$8.69B	$8.56B	$8.83B
Shareholders' equity	$8.85B	$8.61B	$8.73B	$8.62B	$8.70B	$8.47B	$8.31B	$8.05B	$8.17B	$8.01B	$7.96B	$7.88B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$563.80M	$445.50M	$191.50M	$614.20M	$387.20M	$620.60M	$18.50M	$777.20M	$277.30M	$561.10M	-$29.80M	$579.60M
Capital expenditures	$151.60M	$131.60M	$121.00M	$123.90M	$106.70M	$77.90M	$126.00M	$112.10M	$115.80M	$128.20M	$133.80M	$167.20M
Free cash flow	$412.20M	$313.90M	$70.50M	$490.30M	$280.50M	$542.70M	-$107.50M	$665.10M	$161.50M	$432.90M	-$163.60M	$412.40M
Investing cash flow	-$433.70M	-$366.20M	-$322.10M	-$389.90M	-$374.00M	-$94.10M	-$336.00M	-$209.60M	-$579.10M	-$185.00M	-$393.10M	-$330.60M
Financing cash flow	-$10.00M	-$919.90M	$580.50M	-$290.40M	-$59.50M	-$267.40M	-$839.70M	-$546.70M	$1.55B	-$210.00M	-$11.70M	-$446.50M
Dividends paid	$58.20M	$58.70M	$61.20M	$59.30M	$59.90M	$59.90M	$61.60M	$60.10M	$60.50M	$60.40M	$62.10M	$61.10M
Share repurchases	$0	$353.80M	$98.00M	$225.00M	$25.00M	$200.00M	$0	$75.10M	$75.00M	-	-	-$9.00M
Stock-based compensation	$30.80M	$34.90M	$31.70M	$29.70M	$29.20M	$34.10M	$32.80M	$27.30M	$27.00M	$30.80M	$31.60M	$27.00M
Depreciation and amortization	$183.00M	$179.00M	$173.30M	$173.00M	$171.00M	$170.30M	$166.80M	$170.60M	$161.50M	$156.90M	$154.50M	$146.40M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	6.9%	5.8%	5.8%	5.6%	8.6%	9.5%	5.3%	9.8%	7.4%	6.2%	4.6%	3.5%
Net income growth, YoY	0.7%	25.6%	30.5%	14.9%	54.2%	15.9%	-6.7%	-	-7.6%	8.7%	7.1%	-
EPS growth, YoY	3.2%	28.2%	32.9%	15.1%	56.0%	16.9%	-6.3%	-	-5.2%	14.6%	12.6%	-
Gross margin	29.1%	29.8%	28.7%	28.2%	28.8%	29.7%	28.3%	26.9%	27.6%	28.8%	28.2%	27.1%
Operating margin	10.6%	12.1%	10.8%	7.6%	11.1%	11.2%	9.7%	6.5%	7.7%	9.2%	10.1%	-4.0%
Net margin	6.9%	8.0%	7.9%	4.7%	7.3%	6.7%	6.4%	4.3%	5.2%	6.4%	7.2%	-5.5%
Free cash flow margin	10.8%	8.4%	2.0%	13.9%	7.9%	15.4%	-3.2%	20.0%	4.9%	13.4%	-5.2%	13.6%
Current ratio	1.41	1.80	1.73	1.42	1.55	1.50	1.84	1.44	1.44	0.88	0.88	1.17
Debt to equity	0.66	0.68	0.73	0.65	0.58	0.60	0.67	0.79	0.66	0.38	0.38	0.64

Source: XBRL data Labcorp Holdings Inc. files with the SEC, latest filing dated Oct 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

LH peers

Company	Revenue	Growth	Net income	Net margin	Market cap
LH	$14.59B	+6.0%	$1.00B	6.9%	$29.50B
UNHUnitedHealth Group Incorporated	$449.66B	+3.3%	$15.88B	3.5%	$354.57B
ELVElevance Health Inc.	$201.83B	+3.6%	$5.13B	2.5%	$93.34B
CIThe Cigna Group	$286.32B	+6.8%	$5.99B	2.1%	$79.66B
NTRANatera Inc.	$2.91B	+37.4%	-$164.71M	-5.7%	$52.43B
HUMHumana Inc.	$137.20B	+14.1%	$1.13B	0.8%	$49.45B
CNCCentene Corporation	$203.90B	+9.7%	$1.46B	0.7%	$36.72B
ILMNIllumina Inc.	$4.54B	+5.8%	$895.00M	19.7%	$31.45B
DGXQuest Diagnostics Incorporated	$11.84B	+9.1%	$1.13B	9.5%	$28.03B

LH FAQ

9 questions

What is LH revenue?
Labcorp Holdings Inc. (LH) reported $14.59B of revenue for the twelve months ended Sep 30, 2026. That is up 6.0% from the year before. Revenue for fiscal 2025 was $13.95B.
Is LH profitable?
Yes. Labcorp Holdings Inc. earned $1.00B in net income for the twelve months ended Sep 30, 2026, a net margin of 6.9%.
How much cash and debt does LH have?
Labcorp Holdings Inc. reported $261.80M in cash and cash equivalents and $5.85B of debt on its most recent balance sheet in SEC filings.
How fast is LH revenue growing?
Labcorp Holdings Inc.'s revenue changed +7.2% in fiscal 2025, to $13.95B. Its compound annual growth rate was -0.0% over 5 years and +4.9% over 10 years.
What is LH gross margin?
Labcorp Holdings Inc.'s gross profit was $4.23B on $14.59B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 29.0%.
What is LH free cash flow?
Labcorp Holdings Inc. generated $1.29B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.81B less capital expenditures.
What is LH earnings per share?
Diluted earnings per share were $12.19 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did LH last report financial results?
The latest statements here come from Labcorp Holdings Inc.'s 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.
Where does this LH financial data come from?
Quantisnow builds these statements from the structured XBRL data Labcorp Holdings Inc. files with the SEC. It is provided for information only and is not investment advice.